The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kent Richard S since 2013.
The trader's CIK number is 1292660.
At the time of the last reporting, Kent Richard S was the Director of Melinta Therapeutics, Inc. /new/. (stock ticker symbol MLNT).
Also see all insider trading activities at Melinta Therapeutics, Inc. /new/.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | CEMP | 0 | $0 | 0 | $0 | 15,000 | $196,500 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | CMXI | 963,637 | $530,000 | 0 | $0 | 0 | $0 |
1. Melinta Therapeutics, Inc. /new/ (CEMP)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-03-04 | CEMP | Option Ex | 15,000 | 13.10 | 196,500 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-02-22 | CMXI | Buy | 963,637 | .55 | 530,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kent Richard S (Director of Melinta Therapeutics, Inc. /new/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.